Regeneron Pharmaceuticals Other Long-Term Assets 2010-2024 | REGN
Regeneron Pharmaceuticals other long-term assets for the quarter ending September 30, 2024 were $1.043B, a 154.45% increase year-over-year.
- Regeneron Pharmaceuticals other long-term assets for 2023 were $0.444B, a 32.02% increase from 2022.
- Regeneron Pharmaceuticals other long-term assets for 2022 were $0.336B, a 55.67% increase from 2021.
- Regeneron Pharmaceuticals other long-term assets for 2021 were $0.216B, a 28.55% increase from 2020.